Organization Overview
Alternative names
voxelotor (Oxbryta) (NDA)
Anemia (Phase 4)
Anemia, Sickle Cell (Phase 4)
Fibrosis (Phase 2)
Hypoxia (Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 2)
Kidney Diseases (Phase 2)
Liver Diseases (Phase 1)
Pulmonary Fibrosis (Phase 2)
Renal Insufficiency (Phase 1)
Renal Insufficiency, Chronic (Phase 2)